Medicare Enrolled

Dr. Jeffrey Butts, D.O.

Addiction Medicine (Family Medicine) Physician · Boerne, TX
37131 INTERSTATE 10 W, Boerne, TX 78006
8302498400
Registered in NPPES since 2007
NPI: 1831246842 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Butts from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Butts? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Butts

Dr. Jeffrey Butts is an addiction medicine physician in Boerne, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Butts received a total of $3,046 from 24 pharmaceutical and/or device companies across 109 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Butts is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $3,046 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$3,046
Total received (2018-2024)
Avg $435/year across 7 years
Top 23% in TX for addiction medicine (family medicine) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
109
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$926
2023
$426
2022
$545
2021
$197
2020
$119
2019
$309
2018
$525

Payments by company (2024)

Gilead Sciences, Inc.
$269
Otsuka America Pharmaceutical, Inc.
$165
Axsome Therapeutics, Inc.
$104
Indivior Inc.
$94
Teva Pharmaceuticals USA, Inc.
$87
Lundbeck LLC
$71
ABBVIE INC.
$70
Braeburn Inc.
$50
Takeda Pharmaceuticals U.S.A., Inc.
$17
Top 3 companies account for 58.1% of 2024 payments
All-time payments by company (2018-2024) ›
Indivior Inc.
$625
Gilead Sciences, Inc.
$436
Otsuka America Pharmaceutical, Inc.
$415
ABBVIE INC.
$240
Lundbeck LLC
$184
AbbVie Inc.
$157
ITI, Inc.
$146
Axsome Therapeutics, Inc.
$104
Braeburn Inc.
$93
Teva Pharmaceuticals USA, Inc.
$87
Shire North American Group Inc
$81
Allergan, Inc.
$72
Hikma Pharmaceuticals USA
$71
Alkermes, Inc.
$60
Corium, LLC
$48
Bausch Health US, LLC
$38
Supernus Pharmaceuticals, Inc.
$34
Titan Pharmaceuticals, Inc.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$28
BioDelivery Sciences International, Inc.
$26
AstraZeneca Pharmaceuticals LP
$21
Orexo US, Inc.
$17
Eisai Inc.
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
Top 3 companies account for 48.4% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · APLENZIN · AZSTARYS · Austedo XR · Auvelity · BRIXADI · BUNAVAIL 2.1 mg 30-count box · CAPLYTA · Dayvigo · Epclusa · Kloxxado · MAVYRET · MOVANTIK · Probuphine · QELBREE · REXULTI · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · TRINTELLIX · Trintellix · VIVITROL · VRAYLAR · VYVANSE · Vivitrol 380 mg · WELLBUTRIN · XIFAXAN · Zubsolv
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an addiction medicine physician in Boerne?
Compare addiction medicine physicians in the Boerne area by procedure volume, costs, and industry payment transparency.
Browse addiction medicine physicians nearby

Geographic Context

Addiction medicine physicians in nearby ZIP areas
1
County median income
$110,498
Nearest hospital to ZIP centroid (approximate)
SOUTH TEXAS SPINE AND SURGICAL HOSPITAL
20.1 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Butts is an addiction medicine physician, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Butts receive payments from pharmaceutical companies?
Yes. Dr. Butts received a total of $3,046 from 24 companies across 109 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Butts) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Addiction Medicine Physicians in Boerne
Browse addiction medicine physicians in Boerne ranked by procedure volume and transparency data.
Highest volume
Top Addiction Medicine Physicians in TX
Addiction medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Addiction Medicine Physicians in TX
Which TX addiction medicine physicians receive the most from drug and device companies.
By company
Indivior Inc. Payments to Doctors
See all physicians who received payments from Indivior Inc.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →